NRG Therapeutics secures major funding to target Neurodegeneration—Excedr covers the latest funding news.
LB Pharmaceuticals’ $285M IPO fuels schizophrenia drug LB-102—Excedr covers this major biotech funding round.
Learn about lab infrastructure mistakes that can stall funding—and how to build operational credibility that attracts grants and investors.
Learn how CMOs can leverage equipment leasing to streamline manufacturing processes, meet regulatory requirements, and scale biopharmaceutical services.
How can shared labs outperform? By making smarter equipment decisions: prioritizing functionality, flexibility, and real usage over high upfront costs.
Learn how biotech and life sciences labs can scale infrastructure without adding staff—through automation, workflow optimization, and more.
Learn how to scale high-throughput workflows with leased lab equipment. Reduce costs, improve flexibility, and streamline automated lab operations.
Discover how equipment leasing can improve ROI for core facilities—by reducing upfront costs, improving flexibility, and future-proofing lab operations.
Learn how to modernize your R&D lab without a capital budget. Explore cost-effective lab equipment upgrades, leasing strategies, and workflow optimization.
Leasing multiple instruments at once can boost cash flow, simplify procurement, and support scale-up. Here’s why biotechs are bundling their leases.
